Circulation times of prostate cancer and hepatocellular carcinoma cells by in vivo flow cytometry.
about
Performance of computer vision in vivo flow cytometry with low fluorescence contrast.Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis.In vivo flow cytometry: a horizon of opportunities.Near infrared in vivo flow cytometry for tracking fluorescent circulating cells.Circulating tumor cells measurements in hepatocellular carcinoma.No evidence for shedding of circulating tumor cells to the peripheral venous blood as a result of mammographic breast compressionSignal and depth enhancement for in vivo flow cytometer measurement of ear skin by optical clearing agents.The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy.Circulating tumor cells are correlated with disease progression and treatment response in an orthotopic hepatocellular carcinoma model.MicroRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma.An image skeletonization-based tool for pollen tube morphology analysis and phenotyping.Fluorescence detection, enumeration and characterization of single circulating cells <i>in vivo</i>: technology, applications and future prospects.Proportion of circulating tumor cell clusters increases during cancer metastasis.Elongator promotes the migration and invasion of hepatocellular carcinoma cell by the phosphorylation of AKT.Enhanced Specificity in Capturing and Restraining Circulating Tumor Cells with Dual Antibody-Dendrimer Conjugates
P2860
Q30387440-9F39A388-3677-4CA7-BC03-C57F97C691FBQ30445250-9C619895-95C9-4E4B-9660-508F3500B4AEQ30454382-33DD8A5B-0644-4FA3-B5DC-691C5CCC4869Q35681762-45713E45-5A7D-49EF-8660-7669BC7D970EQ36011412-CB59635D-A59F-4490-9A5F-B2982EE19D10Q37202511-3AB2FF5C-516F-4F44-B31D-9F48289C5ECFQ37312578-89D3F4FC-2EEE-429F-927B-EED65783EA82Q38045265-34722773-8561-4B85-BFAF-CFB5AE1C69BEQ38836420-4D69AE12-3FF8-4109-BBFE-EDDA3099E65AQ39150597-3783A271-1573-45BD-BDC2-C313C235753AQ44302433-EA1C1FD6-B017-4512-956E-6899CDE6BEB4Q45305333-93669795-D774-4143-98F2-05F940EB4583Q48719160-88D6EEFE-A120-4745-9881-38CED4577444Q55234457-397232B9-86E1-455E-B61B-C8B7A5A26760Q58641789-4A064623-E291-4A7A-825B-8802DF9E70B6
P2860
Circulation times of prostate cancer and hepatocellular carcinoma cells by in vivo flow cytometry.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Circulation times of prostate ...... lls by in vivo flow cytometry.
@en
Circulation times of prostate ...... lls by in vivo flow cytometry.
@nl
type
label
Circulation times of prostate ...... lls by in vivo flow cytometry.
@en
Circulation times of prostate ...... lls by in vivo flow cytometry.
@nl
prefLabel
Circulation times of prostate ...... lls by in vivo flow cytometry.
@en
Circulation times of prostate ...... lls by in vivo flow cytometry.
@nl
P2093
P2860
P356
P1433
P1476
Circulation times of prostate ...... ells by in vivo flow cytometry
@en
P2093
Chaofeng Wang
Cheng Wang
David Damm
Guangda Liu
Xunbin Wei
Zhengqin Gu
P2860
P304
P356
10.1002/CYTO.A.21134
P577
2011-09-13T00:00:00Z